Novavax, Inc.
NVAX
$5.96
-$0.23-3.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 518.65M | -81.03M | -121.30M | 162.38M | -147.55M |
| Total Depreciation and Amortization | 8.34M | 12.52M | 12.70M | 11.13M | 12.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.11M | -56.00M | 16.15M | 25.53M | 17.58M |
| Change in Net Operating Assets | -739.60M | -48.65M | -52.37M | 115.23M | 34.27M |
| Cash from Operations | -185.50M | -173.16M | -144.81M | 314.27M | -83.56M |
| Capital Expenditure | -1.22M | -1.93M | -1.37M | -2.88M | -6.88M |
| Sale of Property, Plant, and Equipment | -- | 192.64M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.10M | -46.70M | 33.28M | -369.83M | -372.00K |
| Cash from Investing | -73.32M | 144.01M | 31.91M | -372.71M | -7.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.20M | -2.76M | -512.00K | -366.00K | -360.00K |
| Issuance of Common Stock | -- | -- | 415.00K | 257.97M | 6.86M |
| Repurchase of Common Stock | -- | -666.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.86M | -- | -- | 616.00K | -616.00K |
| Cash from Financing | -7.06M | -3.42M | -97.00K | 258.22M | 5.89M |
| Foreign Exchange rate Adjustments | -930.00K | -10.72M | 6.03M | -156.00K | -2.96M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -266.81M | -43.30M | -106.97M | 199.62M | -87.87M |